Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy Saftman

Start price
€34.91
09.12.25 / 50%
Target price
-
09.12.26
Performance (%)
4.81%
Price
€36.59
20:56
Summary
This prediction is currently active. With a performance of 4.81%, the BUY prediction by Saftman for Bayer AG is trending in the right direction. This prediction currently runs until 09.12.26. The prediction end date can be changed by Saftman at any time. Saftman has 50% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w
Bayer AG 4.81%
iShares Core DAX® 1.659%
iShares Nasdaq 100 0.381%
iShares Nikkei 225® 2.102%
iShares S&P 500 0.221%

Comments by Saftman for this prediction

In the thread Bayer AG diskutieren

Saftman hat das Wertpapier Bayer AG in seinem Wikifolio Trendfolge nach Levy gekauft.